MAY 24, 2019 02:01 PM PDT

Blocking this particular protein could slow prostate cancer

Castration-resistant prostate cancer (CRPC) is a particularly aggressive form of prostate cancer. Although the standard of care treatment, which involves disrupting androgen receptor (AR) signaling, is usually effective for 2-3 years, the treatment is not effective long-term and CRPC often develops into lethal metastases.

This is exactly why new research published in Molecular Cancer Research from scientists at Boston University School of Medicine (BUSM) is so exciting. Led by Gerald V. Denis PhD, the BUSM team has determined that blocking a particular protein could prevent the CRPC growth.

"Our findings are significant because current therapeutic options for CRPC are limited and focus primarily on suppressing prostate tumor cells that rely on AR signaling," explained first author Jordan Shafran. "Therefore, it is imperative to identify 'druggable' targets that regulate prostate cancer cell migration and invasion in cells that are either reliant on, or independent of, androgen receptor signaling," he added.

The group of proteins that the researchers investigated is called BET bromodomain proteins and consists of BRD2, BRD3 and BRD4, which regulate gene expression. Following the study’s results, inhibiting the protein BRD4 consistently regulated prostate cancer cell migration and invasion. The same was not found for the proteins BRD2 or BRD3.

The authors elaborate, writing, “We found that BRD4 regulates cell migration across all models of CRPC, regardless of aggressiveness and AR status, whereas BRD2 and BRD3 only regulate migration and invasion in less aggressive models that retain AR expression or signaling. BRD4, a co-regulator of gene transcription, controls migration and invasion through transcription of AHNAK, a large scaffolding protein linked to [the] promotion of metastasis in a diverse set of cancers. Furthermore, treatment of CRPC cell lines with low doses of MZ1, a small-molecule, BRD4-selective degrader, inhibits metastatic potential.”

CRPC is a particularly aggressive form of cancer. Photo: Pixabay

This discovery could have significant implications for the future of CRPC treatments and could offer a new targetable pathway to treat metastatic CRPC, according to the authors.

Sources: Science Daily, Molecular Cancer Research

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 13, 2019
Cancer
DEC 13, 2019
Treating glioblastomas through the bloodstream
New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only p...
DEC 13, 2019
Cardiology
DEC 13, 2019
Exercise Produces Greater Benefits In Those With Cardiovascular Disease
The fact that exercise benefits the heart and can help a person live a longer healthier life is well established. Exercising regularly can improve quality...
DEC 13, 2019
Drug Discovery & Development
DEC 13, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
DEC 13, 2019
Drug Discovery & Development
DEC 13, 2019
Promising Drug for Prostate Cancer
Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Spec...
DEC 13, 2019
Cancer
DEC 13, 2019
Altered DNA methylation controls genes in cancer
New research published in the journal Genome Biology provide new information on genomic structural variation via DNA methylation and its connection to gene...
DEC 13, 2019
Cancer
DEC 13, 2019
Using deep learning to find the patterns of cancer
Research published recently in the journal Life Science Alliance uses deep learning to analyze genomic data from colorectal tumors to ameliorate diagnosis ...
Loading Comments...